{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:28:25Z","timestamp":1788488905184,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T00:00:00Z","timestamp":1556064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T00:00:00Z","timestamp":1556064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 16812"],"award-info":[{"award-number":["IG 16812"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 13025"],"award-info":[{"award-number":["IG 13025"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 18581"],"award-info":[{"award-number":["IG 18581"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["BM1406"],"award-info":[{"award-number":["BM1406"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Previous data from our laboratory show that expression of the P2X7 receptor (P2X7R) is needed for amyloid \u03b2 (A\u03b2)-stimulated microglia activation and IL-1\u03b2 release\n                    <jats:italic>in vitro<\/jats:italic>\n                    and\n                    <jats:italic>in vivo<\/jats:italic>\n                    . We also showed that A\u03b2-dependent stimulation is inhibited by the dihydropyridine nimodipine at an intracellular site distal to the P2X7R. In the present study, we used the N13 microglia cell line and mouse primary microglia from wt and\n                    <jats:italic>P2rx7<\/jats:italic>\n                    -deleted mice to test the effect of nimodipine on amyloid \u03b2 (A\u03b2)-dependent NLRP3 inflammasome expression and function, and on mitochondrial energy metabolism. Our data show that in microglia A\u03b2 causes P2X7R-dependent a) NF\u03baB activation; b) NLRP3 inflammasome expression and function; c) mitochondria toxicity; and these changes are fully inhibited by nimodipine. Our study shows that nimodipine is a powerful blocker of cell damage caused by monomeric and oligomeric A\u03b2, points to the mitochondria as a crucial target, and underlines the permissive role of the P2X7R.\n                  <\/jats:p>","DOI":"10.1038\/s41598-019-42931-2","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T06:03:10Z","timestamp":1556085790000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Amyloid \u03b2-dependent mitochondrial toxicity in mouse microglia requires P2X7 receptor expression and is prevented by nimodipine"],"prefix":"10.1038","volume":"9","author":[{"given":"Paola","family":"Chiozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba Clara","family":"Sarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juana M.","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Lisa","family":"Giuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Adinolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Vultaggio-Poma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Falzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3566-1362","authenticated-orcid":false,"given":"Francesco","family":"Di Virgilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,24]]},"reference":[{"key":"42931_CR1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","volume":"388","author":"P Scheltens","year":"2016","unstructured":"Scheltens, P. et al. Alzheimer\u2019s disease. Lancet 388, 505\u2013517 (2016).","journal-title":"Lancet"},{"key":"42931_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.neuron.2010.10.013","volume":"68","author":"L Bertram","year":"2010","unstructured":"Bertram, L., Lill, C. M. & Tanzi, R. E. The genetics of Alzheimer disease: back to the future. Neuron 68, 270\u2013281 (2010).","journal-title":"Neuron"},{"key":"42931_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3233\/JAD-2006-9S330","volume":"9","author":"PL McGeer","year":"2006","unstructured":"McGeer, P. L., Rogers, J. & McGeer, E. G. Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years. J. Alzheimers. Dis. 9, 271\u2013276 (2006).","journal-title":"J. Alzheimers. Dis."},{"key":"42931_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jneuroim.2009.02.003","volume":"210","author":"A Michelucci","year":"2009","unstructured":"Michelucci, A., Heurtaux, T., Grandbarbe, L., Morga, E. & Heuschling, P. Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: Effects of oligomeric and fibrillar amyloid-beta. J. Neuroimmunol. 210, 3\u201312 (2009).","journal-title":"J. Neuroimmunol."},{"key":"42931_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1159\/000283480","volume":"7","author":"P Eikelenboom","year":"2010","unstructured":"Eikelenboom, P. et al. Neuroinflammation - an early event in both the history and pathogenesis of Alzheimer\u2019s disease. Neurodegener. Dis. 7, 38\u201341 (2010).","journal-title":"Neurodegener. Dis."},{"key":"42931_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0167-5699(91)90032-O","volume":"12","author":"P Vandenabeele","year":"1991","unstructured":"Vandenabeele, P. & Fiers, W. Is amyloidogenesis during Alzheimer\u2019s disease due to an IL-1-\/IL-6-mediated \u2018acute phase response\u2019 in the brain? Immunol. Today 12, 217\u2013219 (1991).","journal-title":"Immunol. Today"},{"key":"42931_CR7","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1002\/glia.22988","volume":"64","author":"PD Wes","year":"2016","unstructured":"Wes, P. D., Sayed, F. A., Bard, F. & Gan, L. Targeting microglia for the treatment of Alzheimer\u2019s Disease. Glia 64, 1710\u20131732 (2016).","journal-title":"Glia"},{"key":"42931_CR8","doi-asserted-by":"publisher","first-page":"S329","DOI":"10.3233\/JAD-179914","volume":"64","author":"A Gutierrez","year":"2018","unstructured":"Gutierrez, A. & Vitorica, J. Toward a New Concept of Alzheimer\u2019s Disease Models: A Perspective from Neuroinflammation. J. Alzheimers. Dis. 64, S329\u2013S338 (2018).","journal-title":"J. Alzheimers. Dis."},{"key":"42931_CR9","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1111\/j.1476-5381.2012.02112.x","volume":"167","author":"JM Sanz","year":"2012","unstructured":"Sanz, J. M. et al. Nimodipine inhibits IL-1beta release stimulated by amyloid beta from microglia. Br. J. Pharmacol. 167, 1702\u20131711 (2012).","journal-title":"Br. J. Pharmacol."},{"key":"42931_CR10","unstructured":"Lopez-Arrieta, J. M. & Birks, J. Nimodipine for primary degenerative, mixed and vascular dementia. Cochrane. Database. Syst. Rev.CD000147 (2002)."},{"key":"42931_CR11","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.neuropharm.2008.10.016","volume":"56","author":"Y Li","year":"2009","unstructured":"Li, Y., Hu, X., Liu, Y., Bao, Y. & An, L. Nimodipine protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation. Neuropharmacology 56, 580\u2013589 (2009).","journal-title":"Neuropharmacology"},{"key":"42931_CR12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0006-8993(98)01272-4","volume":"818","author":"V Silei","year":"1999","unstructured":"Silei, V. et al. Activation of microglial cells by PrP and beta-amyloid fragments raises intracellular calcium through L-type voltage sensitive calcium channels. Brain Res. 818, 168\u2013170 (1999).","journal-title":"Brain Res."},{"key":"42931_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.mcn.2014.12.004","volume":"64","author":"JF Espinosa-Parrilla","year":"2015","unstructured":"Espinosa-Parrilla, J. F., Martinez-Moreno, M., Gasull, X., Mahy, N. & Rodriguez, M. J. The L-type voltage-gated calcium channel modulates microglial pro-inflammatory activity. Mol. Cell Neurosci. 64, 104\u2013115 (2015).","journal-title":"Mol. Cell Neurosci."},{"key":"42931_CR14","doi-asserted-by":"publisher","first-page":"E3295","DOI":"10.1073\/pnas.1620052114","volume":"114","author":"A Schampel","year":"2017","unstructured":"Schampel, A. et al. Nimodipine fosters remyelination in a mouse model of multiple sclerosis and induces microglia-specific apoptosis. Proc. Natl. Acad. Sci. USA 114, E3295\u2013E3304 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"42931_CR15","doi-asserted-by":"publisher","first-page":"4378","DOI":"10.4049\/jimmunol.0803612","volume":"182","author":"JM Sanz","year":"2009","unstructured":"Sanz, J. M. et al. Activation of microglia by amyloid {beta} requires P2X7 receptor expression. J. Immunol. 182, 4378\u20134385 (2009).","journal-title":"J. Immunol."},{"key":"42931_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","volume":"47","author":"F Di Virgilio","year":"2017","unstructured":"Di Virgilio, F., Dal Ben, D., Sarti, A. C., Giuliani, A. L. & Falzoni, S. The P2X7 Receptor in Infection and Inflammation. Immunity. 47, 15\u201331 (2017).","journal-title":"Immunity."},{"key":"42931_CR17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41380-018-0108-3","volume":"24","author":"E Martin","year":"2019","unstructured":"Martin, E. et al. New role of P2X7 receptor in an Alzheimer\u2019s disease mouse model. Mol. Psychiatry 24, 108\u2013125 (2019).","journal-title":"Mol. Psychiatry"},{"key":"42931_CR18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","volume":"75","author":"F Chiti","year":"2006","unstructured":"Chiti, F. & Dobson, C. M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75, 333\u2013366 (2006).","journal-title":"Annu. Rev. Biochem."},{"key":"42931_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","volume":"86","author":"F Chiti","year":"2017","unstructured":"Chiti, F. & Dobson, C. M. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade. Annu. Rev. Biochem. 86, 27\u201368 (2017).","journal-title":"Annu. Rev. Biochem."},{"key":"42931_CR20","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.4049\/jimmunol.156.4.1531","volume":"156","author":"D Ferrari","year":"1996","unstructured":"Ferrari, D. et al. Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. J. Immunol. 156, 1531\u20131539 (1996).","journal-title":"J. Immunol."},{"key":"42931_CR21","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1124\/pr.112.006171","volume":"65","author":"F Di Virgilio","year":"2013","unstructured":"Di Virgilio, F. The therapeutic potential of modifying inflammasomes and NOD-like receptors. Pharmacol. Rev. 65, 872\u2013905 (2013).","journal-title":"Pharmacol. Rev."},{"key":"42931_CR22","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.immuni.2013.05.016","volume":"38","author":"R Munoz-Planillo","year":"2013","unstructured":"Munoz-Planillo, R. et al. K(+) efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity. 38, 1142\u20131153 (2013).","journal-title":"Immunity."},{"key":"42931_CR23","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.1184003","volume":"327","author":"K Schroder","year":"2010","unstructured":"Schroder, K., Zhou, R. & Tschopp, J. The NLRP3 inflammasome: a sensor for metabolic danger? Science 327, 296\u2013300 (2010).","journal-title":"Science"},{"key":"42931_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.mito.2010.08.009","volume":"11","author":"L Tillement","year":"2011","unstructured":"Tillement, L., Lecanu, L. & Papadopoulos, V. Alzheimer\u2019s disease: effects of beta-amyloid on mitochondria. Mitochondrion. 11, 13\u201321 (2011).","journal-title":"Mitochondrion."},{"key":"42931_CR25","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.1091\/mbc.e04-11-1025","volume":"16","author":"E Adinolfi","year":"2005","unstructured":"Adinolfi, E. et al. Basal Activation of the P2X7 ATP Receptor Elevates Mitochondrial Calcium and Potential, Increases Cellular ATP Levels, and Promotes Serum-independent Growth. Mol. Biol. Cell 16, 3260\u20133272 (2005).","journal-title":"Mol. Biol. Cell"},{"key":"42931_CR26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0891-5849(96)00629-6","volume":"23","author":"WR Markesbery","year":"1997","unstructured":"Markesbery, W. R. Oxidative stress hypothesis in Alzheimer\u2019s disease. Free Radic. Biol. Med. 23, 134\u2013147 (1997).","journal-title":"Free Radic. Biol. Med."},{"key":"42931_CR27","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1146\/annurev.bi.38.070169.005015","volume":"38","author":"HA Lardy","year":"1969","unstructured":"Lardy, H. A. & Ferguson, S. M. Oxidative phosphorylation in mitochondria. Annu. Rev. Biochem. 38, 991\u20131034 (1969).","journal-title":"Annu. Rev. Biochem."},{"key":"42931_CR28","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1097\/00001756-200210280-00032","volume":"13","author":"HS Kim","year":"2002","unstructured":"Kim, H. S. et al. Amyloid beta peptide induces cytochrome C release from isolated mitochondria. Neuroreport 13, 1989\u20131993 (2002).","journal-title":"Neuroreport"},{"key":"42931_CR29","doi-asserted-by":"publisher","first-page":"7268","DOI":"10.4049\/jimmunol.174.11.7268","volume":"174","author":"F Bianco","year":"2005","unstructured":"Bianco, F. et al. Astrocyte-derived ATP induces vesicle shedding and IL-1beta release from microglia. J. Immunol. 174, 7268\u20137277 (2005).","journal-title":"J. Immunol."},{"key":"42931_CR30","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1182\/blood-2005-06-031377","volume":"109","author":"C Pizzirani","year":"2007","unstructured":"Pizzirani, C. et al. Stimulation of P2 receptors causes release of IL-1beta-loaded microvesicles from human dendritic cells. Blood 109, 3856\u20133864 (2007).","journal-title":"Blood"},{"key":"42931_CR31","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.1111\/bph.14470","volume":"175","author":"BJ Gu","year":"2018","unstructured":"Gu, B. J. & Wiley, J. S. P2X7 as a scavenger receptor for innate phagocytosis in the brain. Br. J. Pharmacol. 175, 4195\u20134208 (2018).","journal-title":"Br. J. Pharmacol."},{"key":"42931_CR32","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1084\/jem.125.3.457","volume":"125","author":"ZA Cohn","year":"1967","unstructured":"Cohn, Z. A. & Parks, E. The regulation of pinocytosis in mouse macrophages. 3. The induction of vesicle formation by nucleosides and nucleotides. J. Exp. Med. 125, 457\u2013466 (1967).","journal-title":"J. Exp. Med."},{"key":"42931_CR33","unstructured":"Reuters, https:\/\/www.reuters.com\/article\/us-pfizer-alzheimers\/pfizer-ends-research-for-new-alzheimers-parkinsons-drugs-idUSKBN1EW0TN (2018)."},{"key":"42931_CR34","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.phrs.2018.01.017","volume":"130","author":"C Balducci","year":"2018","unstructured":"Balducci, C. & Forloni, G. Novel targets in Alzheimer\u2019s disease: A special focus on microglia. Pharmacol. Res. 130, 402\u2013413 (2018).","journal-title":"Pharmacol. Res."},{"key":"42931_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1017\/S1092852900024901","volume":"14","author":"PH Reddy","year":"2009","unstructured":"Reddy, P. H. Role of mitochondria in neurodegenerative diseases: mitochondria as a therapeutic target in Alzheimer\u2019s disease. CNS. Spectr. 14, 8\u201313 (2009).","journal-title":"CNS. Spectr."},{"key":"42931_CR36","first-page":"259","volume":"146","author":"RH Swerdlow","year":"2017","unstructured":"Swerdlow, R. H. et al. Mitochondria, Cybrids. Aging, and Alzheimer\u2019s Disease. Prog. Mol. Biol. Transl. Sci. 146, 259\u2013302 (2017).","journal-title":"Aging, and Alzheimer\u2019s Disease. Prog. Mol. Biol. Transl. Sci."},{"key":"42931_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11483","volume":"7","author":"SJ Beck","year":"2016","unstructured":"Beck, S. J. et al. Deregulation of mitochondrial F1FO-ATP synthase via OSCP in Alzheimer\u2019s disease. Nat. Commun. 7, 11483 (2016).","journal-title":"Nat. Commun."},{"key":"42931_CR38","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.bbadis.2009.07.005","volume":"1802","author":"H Du","year":"2010","unstructured":"Du, H. & Yan, S. S. Mitochondrial permeability transition pore in Alzheimer\u2019s disease: cyclophilin D and amyloid beta. Biochim. Biophys. Acta 1802, 198\u2013204 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"42931_CR39","doi-asserted-by":"publisher","first-page":"13145","DOI":"10.1073\/pnas.0806192105","volume":"105","author":"CA Hansson Petersen","year":"2008","unstructured":"Hansson Petersen, C. A. et al. The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc. Natl. Acad. Sci. USA 105, 13145\u201313150 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"42931_CR40","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1523\/JNEUROSCI.1136-17.2017","volume":"38","author":"L Rajendran","year":"2018","unstructured":"Rajendran, L. & Paolicelli, R. C. Microglia-Mediated Synapse Loss in Alzheimer\u2019s Disease. J. Neurosci. 38, 2911\u20132919 (2018).","journal-title":"J. Neurosci."},{"key":"42931_CR41","doi-asserted-by":"publisher","first-page":"e60921","DOI":"10.1371\/journal.pone.0060921","volume":"8","author":"G Krabbe","year":"2013","unstructured":"Krabbe, G. et al. Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology. PLoS One 8, e60921 (2013).","journal-title":"PLoS One"},{"key":"42931_CR42","doi-asserted-by":"publisher","first-page":"17318","DOI":"10.1074\/jbc.M112.340885","volume":"287","author":"BJ Gu","year":"2012","unstructured":"Gu, B. J. et al. P2X7 receptor-mediated scavenger activity of mononuclear phagocytes toward non-opsonized particles and apoptotic cells is inhibited by serum glycoproteins but remains active in cerebrospinal fluid. J. Biol. Chem. 287, 17318\u201317330 (2012).","journal-title":"J. Biol. Chem."},{"key":"42931_CR43","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.ajpath.2017.04.016","volume":"187","author":"KA Vessey","year":"2017","unstructured":"Vessey, K. A. et al. Loss of Function of P2X7 Receptor Scavenger Activity in Aging Mice: A Novel Model for Investigating the Early Pathogenesis of Age-Related Macular Degeneration. Am. J. Pathol. 187, 1670\u20131685 (2017).","journal-title":"Am. J. Pathol."},{"key":"42931_CR44","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.4049\/jimmunol.1402845","volume":"195","author":"X Tang","year":"2015","unstructured":"Tang, X., Basavarajappa, D., Haeggstrom, J. Z. & Wan, M. P2X7 Receptor Regulates Internalization of Antimicrobial Peptide LL-37 by Human Macrophages That Promotes Intracellular Pathogen Clearance. J. Immunol. 195, 1191\u20131201 (2015).","journal-title":"J. Immunol."},{"key":"42931_CR45","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1182\/blood-2009-11-251744","volume":"115","author":"BJ Gu","year":"2010","unstructured":"Gu, B. J., Saunders, B. M., Jursik, C. & Wiley, J. S. The P2X7-nonmuscle myosin membrane complex regulates phagocytosis of nonopsonized particles and bacteria by a pathway attenuated by extracellular ATP. Blood 115, 1621\u20131631 (2010).","journal-title":"Blood"},{"key":"42931_CR46","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.trsl.2018.07.014","volume":"202","author":"B Banoth","year":"2018","unstructured":"Banoth, B. & Cassel, S. L. Mitochondria in innate immune signaling. Transl. Res. 202, 52\u201368 (2018).","journal-title":"Transl. Res."},{"key":"42931_CR47","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/nprot.2009.151","volume":"4","author":"MR Wieckowski","year":"2009","unstructured":"Wieckowski, M. R., Giorgi, C., Lebiedzinska, M., Duszynski, J. & Pinton, P. Isolation of mitochondria-associated membranes and mitochondria from animal tissues and cells. Nat. Protoc. 4, 1582\u20131590 (2009).","journal-title":"Nat. Protoc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42931-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42931-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42931-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T20:17:10Z","timestamp":1694809030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42931-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,24]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["42931"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-42931-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,24]]},"assertion":[{"value":"17 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.D.V. is a member of the Scientific Advisory Board of Biosceptre Ltd, a UK-based Company involved in the development of P2X7-targeted antibodies, and has an ongoing collaboration with Ablynx, a Belgian Company involved in the development of P2X7R-targeted nanobodies. Other Authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6475"}}